- Home
- ADEA vs BLFS Comparison
ADEA vs BLFS Comparison
Compare ADEA & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADEA | BLFS |
|---|---|---|
| Founded | 1990 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | 1989 |
Fundamental Metrics
Financial Performance| Metric | ADEA | BLFS |
|---|---|---|
| Price | $17.02 | $24.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $21.00 | ★ $31.50 |
| AVG Volume (30 Days) | ★ 965.7K | 319.0K |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 75.65 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $379,912,000.00 | $100,144,000.00 |
| Revenue This Year | N/A | $20.67 |
| Revenue Next Year | $10.13 | $14.13 |
| P/E Ratio | $26.06 | ★ N/A |
| Revenue Growth | 10.53 | ★ 87.53 |
| 52 Week Low | $10.59 | $19.10 |
| 52 Week High | $18.25 | $29.62 |
Technical Indicators
Market Signals| Indicator | ADEA | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 72.91 | 43.70 |
| Support Level | $12.70 | $24.95 |
| Resistance Level | $18.12 | $25.63 |
| Average True Range (ATR) | 0.64 | 0.78 |
| MACD | 0.60 | 0.07 |
| Stochastic Oscillator | 80.30 | 33.55 |
Price Performance
Historical ComparisonAbout ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.